Biotech Values

[DewDiligence]

These are not happy days for Teva. If their executives hadn’t been such schmoes with respect to Lovenox, the investment community might have been willing to give them the benefit of the doubt on their overall sales and earnings guidance for 2011 and beyond.

As Warren Buffett said, “It takes 20 years to build a reputation and five minutes to ruin it.”